CardioComm Solutions Inc. Announces US$1,500,000 Private Placement.

Business Editors

VICTORIA, British Columbia--(BUSINESS WIRE)--Feb. 4, 2000

(CDNX:CCG)

CardioComm Solutions Inc. (CDNX:CCG) (the &uot;Company&uot;, &uot;CardioComm&uot;) is pleased to announce that, subject to regulatory approval, the Company has agreed to a private placement of up to 3,000,000 units at a price of C$0.75 per unit for net proceeds of up to C$2,250,000.

Each unit consists of one common share of the Company and one half of one non-transferable share purchase warrant exercisable for a period of two years. Each whole warrant entitles the holder to purchase one further common share of the company at a price of $1.00 during the first year and $1.50 during the second year.

The proceeds shall be used for general working capital and for the development of the Company's comprehensive internet based initiatives. The Company technology remains the only practical solution to provide a real-time means of viewing ECGs over a network, including local area networks (LAN), wide area networks (WAN) or the Internet.

In addition, the Company announces that, subject to regulatory approval, it has granted 200,000 incentive stock options to key employees at an exercise price of $0.75 per share. The options are exercisable for a period of five years ending on February 3, 2005.

CardioComm Solutions Inc. is a Canadian company dedicated to providing superior information technology to the field of Cardiology. CardioComm is committed to the containment of cardiovascular disease through improved information access, communication, management, and analysis. CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the only company that provides a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS). GEMS was cleared for sale in the US by the FDA in January of 1999.

For further information on the Company's hardware and software products please contact Mr. Stephen Martin at [phone], EXT 243 or visit the Company's website at http://www.cardiocomm.com.

On behalf of the Board of Directors of CardioComm Solutions Inc.:

&uot;Stephen Martin&uot;

Stephen R. Martin, President &CEO 

The Canadian Venture Exchange has not reviewed and does not accept responsibility for the adequacy or the accuracy of this release.